Sandoz Makes Major Moves To Bolster Biosimilars Ahead Of Spinoff

Announces Development Partnership With Evotec And Investment In Holzkirchen Site

 
• By David Wallace
  
Sandoz logo on building
Sandoz is building up its biosimilars business before spinning off from Novartis • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products